Patients on immunosuppressive therapy for common skin and rheumatic diseases like psoriasis and rheumatoid arthritis are not at increased risk for contracting COVID-19 and should continue taking their...

Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that...

UC San Diego Health has launched a Phase III clinical trial, part of a global effort, to assess whether a medication used to treat rheumatoid arthritis and other inflammatory disorders might also have...

On Friday, the Food and Drug Administration (FDA) approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of Xeljanz, Xeljanz XR (tofacitinib), which is...

The US Food and Drug Administration (FDA) issued a safety alert today concerning the dosing of the rheumatoid arthritis (RA) drug, Xeljanz and Xeljanz XR. A safety clinical trial found an increased risk...

High-dose influenza vaccination substantially improves immune responses against influenza in adults with seropositive rheumatoid arthritis, according to new research findings presented this week at the...

Arthritis is the term used to describe conditions which affect joints and tissues around the joints. Joints are found wherever bones join in the body, e.g. wrists, fingers, ankles, elbows, knees and so...

On Friday, the U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. Amjevita is approved for the following...

The U.S. Food and Drug Administration today approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel (etanercept), which was originally licensed in 1998. Erelzi...

Rheumatoid arthritis patients taking medications that inhibit interleukin-1beta (IL-1beta), a molecule that stimulates the immune system, are 300 times more likely to experience invasive Group A Streptococcal...